Camden National Corporation reported strong third-quarter results, with net interest income increasing 8% year-over-year and earnings per share at $1.36. The bank maintained low loan loss provisions, supporting robust earnings and a well-covered quarterly dividend of $0.42, which is less than one-third of profits. Book value per share reached $42.65, and tangible book value rose to $31.40, reflecting disciplined balance sheet management despite higher interest rates. Trading at about 10 times forward earnings and a premium to tangible book value, Camden National's stock remains attractively valued due to its earnings momentum and prudent underwriting.
Camden National Corporation is highlighted here with its strong earnings and disciplined balance sheet management. For readers following the Financials sector, Pluang's market snapshot as of Oct 29, 2026 21:31 WIB shows that out of 142 priced US financial stocks, 115 rose and 26 fell today. Notable movers include Deutsche Bank AG (DB) at USD 34.64 with a 1-day change of +3.37% and Pluang order activity of 37% Sell / 63% Buy, CleanSpark Inc (CLSK) at USD 8.31 down -3.15%, and Arthur J. Gallagher & Co. (AJG) at USD 268.55 up +3.12%.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
